Research graph
References from Case Report: Dupilumab as a steroid-sparing therapeutic option in refractory anti-p200 pemphigoid: real-world effectiveness in a patient with significant comorbidities. Local targets link to admitted publications; unresolved targets remain external evidence.
Incidence of p200 pemphigoid: A nationwide study
10.1111/jdv.70370 · 2026 · External reference
Coexistence of anti-p200 pemphigoid and psoriasis: A systematic review
10.3389/fimmu.2022.839094 · 2022 · External reference
Treatment and clinical outcomes in anti-p200 pemphigoid: A systematic review
10.1111/jdv.15961 · 2020 · External reference
Anti-p200 pemphigoid in a 17-year-old girl successfully treated with systemic corticosteroid and dapsone
10.1111/j.1365-2133.2007.07810.x · 2007 · External reference
Successful treatment of severe anti-p200 pemphigoid in a heart transplant recipient with a single cycle of rituximab
10.1016/j.jdcr.2017.01.028 · 2017 · External reference
A successful treatment with ustekinumab in a case of antilaminin-gamma1 pemphigoid associated with psoriasis
10.1111/bjd.12163 · 2013 · External reference
A case of anti-laminin gamma1 (p200) pemphigoid with psoriasis vulgaris successfully treated with apremilast
10.1684/ejd.2018.3280 · 2018 · External reference
Successful treatment with guselkumab of anti-p200 pemphigoid associated with plaque psoriasis
10.1111/ddg.15364 · 2024 · External reference
Anti-laminin gamma1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone
10.1111/1346-8138.16864 · 2023 · External reference
Anti-p200 pemphigoid with autoantibodies targeting laminin beta-4 and clinical response to methotrexate
10.1016/j.jdcr.2025.02.051 · 2025 · External reference
A case report of IgA-mediated anti-laminin-gamma1 (p200) pemphigoid successfully treated with stapokibart combined with corticosteroids
10.3389/fimmu.2026.1767277 · 2026 · External reference
Refractory bullous pemphigoid with IgE anti-BP230 and IgG anti-p200 antibodies successfully treated with omalizumab
10.1016/j.annder.2020.08.053 · 2021 · External reference